Artal Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35,000
| Closed | -$2.43M | – | 128 |
|
|
2022
Q4 | $2.43M | Hold |
35,000
| – | – | 0.14% | 78 |
|
|
2022
Q3 | $5.13M | Hold |
35,000
| – | – | 0.22% | 55 |
|
|
2022
Q2 | $4.56M | Hold |
35,000
| – | – | 0.24% | 61 |
|
|
2022
Q1 | $3.54M | Hold |
35,000
| – | – | 0.15% | 93 |
|
|
2021
Q4 | $5.42M | Hold |
35,000
| – | – | 0.15% | 93 |
|
|
2021
Q3 | $10.4M | Hold |
35,000
| – | – | 0.23% | 73 |
|
|
2021
Q2 | $11.4M | Buy |
+35,000
| New | +$11.4M | 0.23% | 77 |
|